The drug industry’s stake in Trumpcare is bigger than you think

(By Dylan Scott for STAT)

WASHINGTON — The upcoming fight over repealing and replacing the Affordable Care Act1 promises to shake up hospitals and insurers, but drug makers also stand to gain — or lose — a lot. Continue reading article here…

stat-logo

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.